Gapping up
In reaction to earnings/guidance:
- WW +13.7% (also buying Sequence for $106 mln net), SQSP +13.6%, SE +10.1%, DOLE +5%, DKS +4.8%, TCOM +2.9%, ESAB +2.1%, GWRE +1.4%, SWIM +1.2%, VRNA +1.1%, AVAV +0.5%
Other news:
- GSAT +2.6% (collaborating with Qualcomm)
- TDW +2.1% (acquires 37 platform supply vessels from Solstad Offshore)
- TEAM +1.9% (rebalancing of resources resulting in the elimination of certain roles impacting about 500 full-time employees or approximately 5% of the Company's current workforce)
- IONS +1.2% (FDA accepts NDA for eplontersen)
- SNY +1.1% (Sanofi and Regeneron Pharmaceuticals (REGN) report Dupixent accepted for FDA review)
Analyst comments:
- ANET +1.3% (initiated with a Buy at Goldman)
- JNPR +1% (initiated with a Buy at Goldman)
- COST +0.7% (upgraded to Buy from Neutral at Northcoast)